Herpes simplex encephalitis in patients with cancer
- 3 June 2011
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 105 (2) , 415-421
Abstract
Case reports and animal models suggest that chemotherapy, corticosteroids and radiotherapy (RT) may increase the risk of herpes simplex encephalitis (HSE). We retrospectively examined cases of HSE at an academic hospital devoted to cancer care. Patients were identified by positive herpes simplex virus (HSV) polymerase chain reaction (PCR) in cerebrospinal fluid (CSF) or by brain pathology. There were seven patients with HSE over a 12 year period, four of whom had received cranial RT. During this time, a total of 997 patients were treated with cranial RT, suggesting a greater incidence than the expected risk of two to four cases per million people per year in the general population. Five patients had recently received chemotherapy and three were on dexamethasone. MRI findings were typical; four patients had bilateral anterior temporal lesions and three had unilateral-temporal lesions. Four patients had a normal CSF white blood cell count, three of whom had prior RT and dexamethasone. Four patients were positive for HSV-1, and two for HSV-2. One patient had a negative CSF PCR for HSV, but autopsy confirmed active HSE. Though still rare, the risk of HSE may be increased in patients with cancer, especially in those receiving cranial RT. MRI findings were typical, but CSF white blood cell count was normal in four patients and one had negative CSF testing, suggesting that CSF results may be misleading in this population.Keywords
This publication has 38 references indexed in Scilit:
- Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agentsHaematologica, 2010
- Infectious Encephalitis in France in 2007: A National Prospective StudyClinical Infectious Diseases, 2009
- Herpes simplex virus encephalitis after allogeneic transplantation: an instructive caseBone Marrow Transplantation, 2009
- Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]BMC Neurology, 2008
- Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNETPediatric Blood & Cancer, 2008
- Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humansCurrent Opinion in Allergy and Clinical Immunology, 2007
- Irradiation Does Not Compromise or Exacerbate the Innate Immune Response in the Brains of Mice That Were Transplanted with Bone Marrow Stem CellsStem Cells, 2007
- Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterizationJournal of Clinical Virology, 2005
- Postoperative Herpes Simplex Virus Encephalitis after Neurosurgery: Case Report and Review of the LiteratureClinical Infectious Diseases, 2003
- Herpes simplexencephalitis in multiple myelomaAustralian and New Zealand Journal of Medicine, 1999